Comparison · NCT01366196-1f2e54b5
Pregabalin Group (P) vs Control Group (C): Oral Analgesic Supplementation Use
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
2 sourcestrial-comparisons-2026-03-23-0.1.0
Cite this record
ConductScience Library. Pregabalin Group (P) vs Control Group (C): Oral Analgesic Supplementation Use. Trial comparisons, record NCT01366196-1f2e54b5. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT01366196-1f2e54b5
On this page
Measures6
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
| Measure | Value | 95% interval, lower | 95% interval, upper | Method | Note |
|---|---|---|---|---|---|
| Risk in group 1 | 0.488 | 0.346 | 0.632 | wilson | |
| Risk in group 2 | 0.581 | 0.433 | 0.716 | wilson | |
| Risk difference, group 1 minus group 2 | -0.093 | -0.289 | 0.114 | newcombe hybrid score | |
| Risk ratio, group 1 over group 2 | 0.84 | 0.565 | 1.25 | log | |
| Odds ratio, group 1 over group 2 | 0.687 | 0.293 | 1.61 | log | |
| Number needed to treat, for one fewer participant with the outcome on Pregabalin Group (P) than on Control Group (C) | 10.7 | from the risk difference interval | the interval includes no difference |
Source ClinicalTrials.gov
Groups2
Group 2 names the comparator: control.
| Group | Title | Description | With the outcome | Analysed | ClinicalTrials.gov code |
|---|---|---|---|---|---|
| Group 1 | Pregabalin Group (P) | Patients in the treatment group will receive 150 mg of pregabalin with a sip of water one hour prior to surgery, and then 150 mg daily (75 mg BID) for a total of two weeks. | 21 | 43 | OG001 |
| Group 2 | Control Group (C) | Patients in the control group will receive a placebo tablet with a sip of water one hour prior to surgery and a placebo tablet twice a day for a total of two weeks. | 25 | 43 | OG000 |
Source ClinicalTrials.gov
Outcome
- Type
- SECONDARY
- Title
- Oral Analgesic Supplementation Use
- Description
- Tabulate number of patients that used supplemental oral analgesics
- Time frame
- Day of surgery
- Population
Source ClinicalTrials.gov
Trial
- Title
- Pregabalin for the Treatment of Pain After Posterior Spinal Fusions
- NCT number
- NCT01366196
- Phases
- NA
- Conditions
- Lumbar Spinal Fusions
- Interventions
- Pregabalin 150 mg, Placebo
- Lead sponsor
- Hospital for Special Surgery, New York
- Results first posted
- 2017-06-21
- Results on ClinicalTrials.gov
- https://clinicaltrials.gov/study/NCT01366196?tab=results
Source ClinicalTrials.gov
Source
- Release
- trial-comparisons-2026-03-23-0.1.0
- Release manifest SHA-256
- f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
- AACT copy
- 2026-03-23
- Tables read
- outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet
Source ClinicalTrials.gov
Sources 2
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.
For software
Read this comparison from software.
The record is JSON. No key.
GET https://conductscience.org/api/comparisons/v1/NCT01366196-1f2e54b5